Jove
Visualize
联系我们

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

820
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
820

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A computational model to describe multi-regional brain architecture during neurodegeneration in Alzheimer's disease.

Scientific reports·2026
Same author

Advances in the drug treatment of Alzheimer's disease: pathophysiology and mechanisms of action.

BMJ (Clinical research ed.)·2026
Same author

Correlation between epicardial adipose tissue and cognitive performance in older adults. A role for autonomic nervous system imbalance?

Frontiers in aging·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jan 24, 2026

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

16.7K

生物标志物 生物标志物

Gemma Natalie Wright1, James Neil Dodds1, Rifa Sanjida Punnota2

  • 1Imperial College London, London, London, United Kingdom.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|January 22, 2026
PubMed
概括
此摘要是机器生成的。

在阿尔茨海默病 (AD) 患者中,大脑脊髓液 (CSF) 粉样蛋白和PET成像结果之间存在10.5%的不一致. 不和的个体显示出较低水平的病理,这表明其他神经退行性过程可能参与其中.

更多相关视频

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

755
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.0K

相关实验视频

Last Updated: Jan 24, 2026

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

16.7K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

755
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.0K

科学领域:

  • 神经学 神经学
  • 生物标志物研究 生物标志物研究
  • 阿尔茨海默氏症疾病的诊断方法

背景情况:

  • 阿尔茨海默病 (AD) 研究越来越多地关注大脑脊髓液 (CSF) 的生物标志物.
  • 脑液和PET成像用于确定AD中的粉样蛋白状况,尽管可能出现不一致的结果.
  • 在阿尔茨海默氏症中,不一致的粉样蛋白状况的比例和临床影响仍然不清楚.

研究的目的:

  • 在阿尔茨海默氏病中调查脑液Aβ42:40和PET粉样蛋白状况之间的不一致率.
  • 评估是否不一致的粉样蛋白状态与不同水平的tau聚合和临床特征有关.

主要方法:

  • 利用了阿尔茨海默病神经成像计划 (ADNI) 数据库中的313名参与者的数据.
  • 使用ROC曲线分析的Youden指数计算了CSFAβ42:40的截止值 (截止值=0.057).
  • 进行了t测试,以比较一致和不一致组之间的临床和tau病理差异.

主要成果:

  • 在CSF Aβ42:40和PET粉样蛋白状态之间观察到10.5%的不一致率 (33名313名参与者中).
  • 与一致的个体相比,不一致的个体表现出明显较低的酸化tau 181 (pTau181) 和总tau水平.
  • 对于pTau181 (t(71.2) =-3.166,p=.002) 和Tau (t(53.9) =-2.046,p=.046) 的差异,发现了统计学意义.

结论:

  • 不一致的群体中的不同水平表明,其他病理过程可能会导致这些阿尔茨海默病患者的神经退行.
  • 观察到的10%的不一致性强调了在将这些个体纳入干预研究之前需要对这些个体进行详细评估的必要性.
  • 需要进一步的研究,以了解非一致的粉样蛋白状况对阿尔茨海默氏病的进展和治疗的影响.